Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis

Author： Główka Franciszek  

Publisher： Springer Publishing Company

ISSN： 0378-7966

Source： European Journal of Drug Metabolism and Pharmacokinetics, Vol.36, Iss.3, 2011-09, pp. : 167-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia   Roots Ivar   Goldammer Mark   Rosenkranz Bernd  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Effect of CYP2C9 polymorphisms on pharmacokinetics of nateglinide

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 3, 2016-05 ,pp. : 170-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers

By Kirchheiner J.  

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite

The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

By  

Current Clinical Pharmacology, Vol. 2, Iss. 1, 2007-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite